Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
As of early 2026, retatrutide is in Phase 3 clinical trials (the TRIUMPH program)
Using a lower volume of bacteriostatic water produces a more concentrated solution (smaller injection volume per dose)
These are rare at the doses used in supervised clinical care and when they occur, they're typically mild and transient
ButyroGen is a registered trademark of NutriScience Innovations, LLC for their tributyrin complex
US$ 27.71
US$ 28.30
US$ 22.03
US$ 22.37
US$ 29.06
